메뉴 건너뛰기




Volumn 49, Issue 9, 2010, Pages 1793-1794

Comment on: Efficacy and safety of anti-tnf therapies in psoriatic arthritis: An observational study from the british society for rheumatology biologics register

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ANTIBODY;

EID: 77955756217     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq138     Document Type: Letter
Times cited : (4)

References (5)
  • 1
    • 77953480860 scopus 로고    scopus 로고
    • Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register
    • Saad AA, Ashcroft DM, Watson KD, Symmons DP, Noyce PR, Hyrich KL. Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register. Rheumatology 2010;49:697-705.
    • (2010) Rheumatology , vol.49 , pp. 697-705
    • Saad, A.A.1    Ashcroft, D.M.2    Watson, K.D.3    Symmons, D.P.4    Noyce, P.R.5    Hyrich, K.L.6
  • 2
    • 33750331541 scopus 로고    scopus 로고
    • Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors
    • Fransen J, Antoni C, Mease PJ et al. Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors. Ann Rheum Dis 2006;65:1373-8.
    • (2006) Ann Rheum Dis , vol.65 , pp. 1373-1378
    • Fransen, J.1    Antoni, C.2    Mease, P.J.3
  • 3
    • 73449100479 scopus 로고    scopus 로고
    • Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment
    • Coates LC, Fransen J, Helliwell PS. Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis 2010;69: 48-53.
    • (2010) Ann Rheum Dis , vol.69 , pp. 48-53
    • Coates, L.C.1    Fransen, J.2    Helliwell, P.S.3
  • 4
    • 77954259617 scopus 로고    scopus 로고
    • Validation of minimal disease activity (MDA) criteria for psoriatic arthritis using interventional trial data
    • doi:10.1002/acr.20155
    • Coates LC, Helliwell PS. Validation of minimal disease activity (MDA) criteria for psoriatic arthritis using interventional trial data. Arthritis Care Res. Advance Access published February 23, 2010, doi:10.1002/acr.20155.
    • (2010) Arthritis Care Res. Advance Access published February , vol.23
    • Coates, L.C.1    Helliwell, P.S.2
  • 5
    • 77954304374 scopus 로고    scopus 로고
    • Frequency, predictors and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort
    • Advance Access published February 26, doi:10.1002/acr.20162
    • Coates LC, Cook RJ, Lee K, Chandran V, Gladman DD. Frequency, predictors and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort. Arthritis Care Res. Advance Access published February 26, 2010, doi:10.1002/acr.20162.
    • (2010) Arthritis Care Res
    • Coates, L.C.1    Cook, R.J.2    Lee, K.3    Chandran, V.4    Gladman, D.D.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.